Sell Before the Cliff: A Business Development Playbook for Sterile Manufacturing Suppliers Targeting Biologic Loss of Exclusivity
The Patent Cliff Is Not an Event. It’s a Calendar. Every biologic drug that ever earned blockbuster status is on […]
Drug Switching Questions: What Patients Are Really Asking Online
Across hundreds of DrugChatter queries, a clear pattern emerges: patients and caregivers are not just asking about drugs—they’re asking what
Drug Switching Questions: What Patients Are Really Asking Online Read Post »
Beat the Brand: Using Patent Intelligence to Anticipate and Defeat Drug Patent Evergreening
The Evergreening Problem, Defined Precisely Evergreening is not a conspiracy. It is a rational economic strategy executed by legal means,
Squeeze the Patent: How Drug Companies Use Reformulation and New Indications to Outlast Generic Competition
The blockbuster drug model has a built-in expiration date. From the moment a pharmaceutical company files its first patent, the
GPT-Rosalind and Generic Drugs: What OpenAI’s Life Sciences Model Actually Changes
Part One: What GPT-Rosalind Is and What OpenAI Is Selling The Model Architecture GPT-Rosalind is the first in what OpenAI
GPT-Rosalind and Generic Drugs: What OpenAI’s Life Sciences Model Actually Changes Read Post »
Beat the Patent Cliff: How to Trigger Payer Strategy Campaigns Before Drug Patent LOE
A systematic, intelligence-led playbook for commercial and market access vendors targeting pre-LOE mandates with health plans, PBMs, IDNs, and brand
Beat the Patent Cliff: How to Trigger Payer Strategy Campaigns Before Drug Patent LOE Read Post »
OpenAI’s GPT-Rosalind = Smashed Drug Patent Cliffs and 70% Faster ANDAs
The launch of OpenAI GPT-Rosalind on April 17, 2026, marks the end of the traditional patent cliff as a predictable
OpenAI’s GPT-Rosalind = Smashed Drug Patent Cliffs and 70% Faster ANDAs Read Post »
Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats
The Generic Entry Problem Nobody States Plainly Every branded pharmaceutical product has a clock on it. The moment the FDA
Know Exactly How Long Your Drug Patent Lasts in the GCC
Why the GCC Derails Pharma IP Teams That Know the U.S. System Cold There is a particular category of expensive
Know Exactly How Long Your Drug Patent Lasts in the GCC Read Post »
